基本信息
浏览量:530
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
The main research focus of James R. Cerhan, M.D., Ph.D., is using epidemiologic approaches to study the causes and outcomes of cancer in human populations.
Focus areas
Identifying the causes of lymphoma. This research program identifies the environmental, lifestyle, genetic and biological factors that are responsible for causing lymphoma, a cancer of the immune system that increased dramatically during the second half of the 20th century. Dr. Cerhan uses large epidemiologic studies (both cohort and case-control studies) combined with state-of-the-art technologies to determine these factors and understand their underlying mechanisms.
Improving the outcomes of patients with lymphoma. Dr. Cerhan's second major research aspect identifies lifestyle, genetic, tumor and treatment factors that lead to improved survival, overall health and quality of life of lymphoma patients. In collaboration with clinicians, pathologists, immunologists, behavioral scientists, statisticians, bioinformaticians and other disciplines, he follows a large cohort of lymphoma patients, addressing survivorship over the short and long term.
Building and sustaining infrastructure to facilitate human research. As principal investigator of the Mayo Clinic Biobank, Dr. Cerhan oversees the building of a biobank of 50,000 participants who donate biologic samples and clinical and risk factor data, which can be used in multiple research studies. At the Mayo Clinic Cancer Registry, he oversees the collection of systematic data on all newly diagnosed cancer patients, which is used for state and national reporting, quality improvement, and research to improve cancer care.
Focus areas
Identifying the causes of lymphoma. This research program identifies the environmental, lifestyle, genetic and biological factors that are responsible for causing lymphoma, a cancer of the immune system that increased dramatically during the second half of the 20th century. Dr. Cerhan uses large epidemiologic studies (both cohort and case-control studies) combined with state-of-the-art technologies to determine these factors and understand their underlying mechanisms.
Improving the outcomes of patients with lymphoma. Dr. Cerhan's second major research aspect identifies lifestyle, genetic, tumor and treatment factors that lead to improved survival, overall health and quality of life of lymphoma patients. In collaboration with clinicians, pathologists, immunologists, behavioral scientists, statisticians, bioinformaticians and other disciplines, he follows a large cohort of lymphoma patients, addressing survivorship over the short and long term.
Building and sustaining infrastructure to facilitate human research. As principal investigator of the Mayo Clinic Biobank, Dr. Cerhan oversees the building of a biobank of 50,000 participants who donate biologic samples and clinical and risk factor data, which can be used in multiple research studies. At the Mayo Clinic Cancer Registry, he oversees the collection of systematic data on all newly diagnosed cancer patients, which is used for state and national reporting, quality improvement, and research to improve cancer care.
研究兴趣
论文共 1157 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
STATISTICS IN MEDICINEno. 7 (2024): 1441-1457
Nature Reviews Rheumatologyno. 5 (2024): 1-11
Journal of the American College of Cardiologyno. 13 (2024): 2653
Chung-il Wi, Madison J. Roy,Euijung Ryu,Philip H. Wheeler,Gokhan Anil, Kathy A. Madden,Folakemi T. Odedina,James R. Cerhan,Young J. Juhn
Journal of Clinical and Translational Scienceno. s1 (2024): 30-30
Sivaraman Rajaganapathy,Shaika Chowdhury, Vincent Buchner,Zhe He,Xiaoqian Jiang, Ping Yang,James R Cerhan,Nansu Zong
medRxiv : the preprint server for health sciences (2024)
Blood advances (2024)
Blood advancesno. 17 (2024): 4559-4562
Blood advancesno. 9 (2024): 2172-2181
Journal of the American Medical Informatics Association : JAMIAno. 8 (2024): 1671-1681
加载更多
作者统计
#Papers: 1145
#Citation: 53865
H-Index: 114
G-Index: 205
Sociability: 9
Diversity: 3
Activity: 189
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn